This page contains brief details about the drug , it's indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Background and Date of Approval
The U.S. FDA approved Saroglitazar for neurological disorders on February 13. Saroglitazar belongs to the medication class called dual peroxisome proliferator-activated receptor (PPAR) agonist. It works by managing high cholesterol and triglycerides, along with blood sugar levels in type 2 diabetes.
Mechanism of Action of undefined
Saroglitazar works by managing high cholesterol and triglycerides, along with blood sugar levels in type 2 diabetes. Its unique mechanism reduces the synthesis and secretion of triglycerides, improving insulin sensitivity for better utilization and lowering blood sugar levels.
Uses of undefined
Saroglitazar is used to treat diabetic dyslipidemia (an abnormal amount of lipids in the blood) and hypertriglyceridemia (high level of triglycerides in the blood) in patients with type 2 diabetes mellitus that is not controlled by statin therapy.
undefined Drug administaration and Dosage available
Take the Saroglitazar as your physician advises. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.
Warnings, Precautions and Side Effects of undefined
Saroglitazar should not be consumed if you are allergic to Saroglitazar or any of its ingredients in the medication. Before using this medicine, let your doctor know if you have any liver or kidney problems or a history of muscle issues. If you have heart disease, be cautious as this medicine hasn't been studied in severe heart failure patients. Although uncommon, watch for rapid weight gain, which may be a sign of swelling and heart-related symptoms. If you experience any concerning symptoms, contact your doctor right away.
Before starting the treatment, inform your doctor if you are pregnant, think you may be pregnant, or planning to get pregnant or breastfeeding. The safety and effectiveness of Saroglitazar have not been confirmed for use in children. Patients with liver, heart, and kidney conditions should take Saroglitazar cautiously and should inform the doctor about all the underlying medical conditions.
The most common side effects of Saroglitazar are gastritis (stomach inflammation), nausea, vomiting, asthenia (weakness), chest discomfort, dizziness, fever, and weakness.
Word Of Advice
Do not stop the medicine until your doctor advises. Do not double-dose the medicine to make up for a forgotten dose. Notify your doctor if you experience any serious side effects. Your medical professional will inform you if you need any dose adjustments. Contact your doctor for more information. Keep out of sight and reach of pets and children. Do not freeze the medicine. Always check the expiry date before consuming it.
Frequently Asked Question
- Saroglitazar; [Accessed 20th July 2023]; lipaglyn.com/downloads/Lipaglyn_PI_Booklet.pdf
- Clinical trials, [Accessed 20th July 2023] https://www.clinicaltrialsarena.com/projects/lipaglyn-saroglitazar-treating-type-ii-diabetes/
The drug information on this page is not a substitute for medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you are eligible to receive this treatment.